| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/16/2000 | CN1263155A New human protein and its coding sequence |
| 08/16/2000 | CN1263154A Human tumor suppressor gene |
| 08/16/2000 | CN1263107A Ribosome deactivated protein-pumpkin protein |
| 08/16/2000 | CN1263106A Small molecule ribosome deactivated protein |
| 08/16/2000 | CN1055501C Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus |
| 08/16/2000 | CN1055500C DNA sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom |
| 08/16/2000 | CN1055499C Regulatory nucleotde sequence of initiation of transcription |
| 08/16/2000 | CN1055480C Substitution analogues of magainin peptides |
| 08/16/2000 | CA2296764A1 Growth hormone-regulated growth marker |
| 08/15/2000 | US6103888 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
| 08/15/2000 | US6103887 For diagnosis of cell proliferation and tumorigenesis especially related to hepatocellular carcinoma; antisense agents; anticarcinogenic agents; antitumor agents |
| 08/15/2000 | US6103886 Testis-specific dna which encodes a polypeptide of defined amino acid sequence; for probes and primers to diagnosis individuals with missing or altered sequence related to infertility or reduced sperm count |
| 08/15/2000 | US6103882 Producing a peptide ligand, amide or salt by subjecting fusion protein or peptide to cleavage of the peptide bond on the amino terminal side of a cysteine in the heterologous peptide |
| 08/15/2000 | US6103880 Amino acid sequence of mitogenic peptide; angiogenic agents especially for brain structures; wound healing agents for skin; for bone regeneration especially osteoporosis |
| 08/15/2000 | US6103879 Bivalent molecules that form an activating complex with an erythropoietin receptor |
| 08/15/2000 | US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer |
| 08/15/2000 | US6103876 Isolated antibody that binds to human or bovine beta-migrating endothelial cell plasminogen activator inhibitor |
| 08/15/2000 | US6103875 Antifungal compounds from pseudomonas viridiflava |
| 08/15/2000 | US6103874 Human KDEL receptor |
| 08/15/2000 | US6103873 Isolated renal cancer specific antigen |
| 08/15/2000 | US6103872 Rat protein of specific amino acid sequence which binds to the pdz domain of a mammalian nitric oxide synthase; for neurotransmitter regulation and therapy of related nervous system disorders |
| 08/15/2000 | US6103870 CS-1 peptidomimetic, compositions and methods of using the same |
| 08/15/2000 | US6103869 Isolated polypeptide with a mutation at amino acid 464, 465, and/or 467 resulting in dominant negative inhibition of transforming growth factor-beta signaling; therapy and diagnosis of related diseases |
| 08/15/2000 | US6103710 Glucocorticoid response elements |
| 08/15/2000 | US6103693 Method for isolation of highly pure von willebrand factor |
| 08/15/2000 | US6103692 Administering to said mammal, or contacting said cells with, a compound which inhibits lipid-dependent direct binding of a non-effector loop domain of ras with a raf zinc finger domain |
| 08/15/2000 | US6103691 Administering an agent containing one or more active ingredients selected from the group consisting of angiogenine, alpha1-microglobulin, complement factor d, fragments or peptides |
| 08/15/2000 | US6103531 Decreasing levels of janus kinase i by introducing isolated gene product of cytomegalovirus early gene, immediate early gene or mixture into cell |
| 08/15/2000 | US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy |
| 08/15/2000 | US6103526 Insect cell line, atcc crl-12579; use in recombinant baculovirus expression systems for production of proteins such as erythropoietin, neuraminidase, cd4, thrombospondin, carcinoembryonic antigen, and influenza hemagglutinin |
| 08/15/2000 | US6103524 Amino acid and nucleotide sequences; for prevention and therapy of acute and chronic neurodegenerative conditions, and as antipsychotic, anticonvulsant, analgesic, anxiolytic, antidepressant, and antiemetic agents |
| 08/15/2000 | US6103521 Multispecific chimeric receptors |
| 08/15/2000 | US6103519 Recombinant dna including coding sequence and regulatory sequence for expression of l protein with modified or deleted regions; for hepatitis vaccines |
| 08/15/2000 | US6103515 Microorganism defective in preferential proteolytic acivities; for the therapy and prophylaxis of thrombosis, shock and coagulation defects; for use as diuretic, vasorelaxant and to control cardiovascular equlibrium |
| 08/15/2000 | US6103507 Protein used to raise an immunological response against a bacteria; bactericides |
| 08/15/2000 | US6103502 Ultrafiltration process for desalination and concentration of a peptide in a cell-free fermentation medium |
| 08/15/2000 | US6103501 Recombinant protein which can be utilized as agonist or antagonist to its native cellular counterparts |
| 08/15/2000 | US6103500 Production of tissue factor pathway inhibitor |
| 08/15/2000 | US6103499 Inhibitors of human plasmin derived from the Kunitz domains |
| 08/15/2000 | US6103498 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof |
| 08/15/2000 | US6103497 Human S100 proteins |
| 08/15/2000 | US6103495 Direct expression of peptides into culture media |
| 08/15/2000 | US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response |
| 08/15/2000 | US6103493 Genetically engineered polypeptide to be used as a diagnostic tool in the detection of compounds |
| 08/15/2000 | US6103492 Polynucleotide encoding mu opioid receptor |
| 08/15/2000 | US6103491 Methods and compositions for identifying morphogen analogs |
| 08/15/2000 | US6103484 Method for immunodiagnosis of heartworm in mammals |
| 08/15/2000 | US6103483 Labeling a polypeptide having a truncated portion of a prosaposin molecule, with a light sensitive probe, contacting probe with a sperm sample and exposing to a light source, measuring anount of probe per sperm which reacts with light |
| 08/15/2000 | US6103477 Rho protein |
| 08/15/2000 | US6103475 Excitatory amino acid receptor protein expression testing methods |
| 08/15/2000 | US6103466 Obtaining dna sample from mammal and determining if nucleotide sequence encodes a biologically active protein of myostatin; amplifying dna with primers flanking natural mutation which when present in both alleles results in muscular hyperplasia |
| 08/15/2000 | US6103244 Containing a heterologous insert encoding an immunogenic protein, wherein said insert was molecularly cloned directly into the viral genome into a unique restriction endonuclease cleavage site |
| 08/15/2000 | US6103239 Modified HGP-30 heteroconjugates, compositions and methods of use |
| 08/15/2000 | US6103238 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines |
| 08/15/2000 | US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2) |
| 08/15/2000 | US6103233 Cellular and serum protein anchors and conjugates |
| 08/15/2000 | US6103232 Use of antibodies to the central nervous system myelin associated proteins; the monoclonal antibody in-1 and in-2 may be used to promote neurite outgrowth of nerve fibers over long distances in spinal cord lesions. |
| 08/15/2000 | US6103229 Regulator gene from Ustilago maydis |
| 08/15/2000 | US6103228 Antibiotic-producing and metabolite-producing bacillus subtilis strain that exhibits insecticidal activity |
| 08/15/2000 | US6103224 N∇2 CSF-1 (short form) and carboxy truncated fragments thereof |
| 08/15/2000 | CA2296846A1 Dna fragments having basidiomycete-derived promoter activity and expression of foreign genes under control of the promoter activity |
| 08/15/2000 | CA2196431C Icam-4 materials and methods |
| 08/15/2000 | CA2058930C Media for cell growth and method for making them |
| 08/15/2000 | CA2046601C Production and use of anthelmintic agents and protective immunogens |
| 08/15/2000 | CA2034484C Radioimmunotherapy using .alpha.-particles emission |
| 08/15/2000 | CA1341083C Purified recombinant interleukin-2 and process for recovering and purifying same |
| 08/10/2000 | WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/10/2000 | WO2000046390A1 T helper cell epitopes |
| 08/10/2000 | WO2000046384A1 Nucleic acid uptake and release vehicle |
| 08/10/2000 | WO2000046383A2 Method of modulating metabolite biosynthesis in recombinant cells |
| 08/10/2000 | WO2000046381A1 Recombinant expression of heterologous nucleic acids in protozoa |
| 08/10/2000 | WO2000046380A2 Fibroblast growth factor receptor-immunoglobulin fusion |
| 08/10/2000 | WO2000046376A2 Particles for gene therapy |
| 08/10/2000 | WO2000046375A2 Methods for producing polypeptides in fungal cells |
| 08/10/2000 | WO2000046374A1 $i(candida albicans) srb-7 |
| 08/10/2000 | WO2000046373A1 Diagnostic and protective antigen gene sequences of ichthyophthirius |
| 08/10/2000 | WO2000046372A2 Pancreatic islet genes regulated by glucose |
| 08/10/2000 | WO2000046371A1 Tau-conotoxin peptides |
| 08/10/2000 | WO2000046370A1 P37ing1 compositions and methods of use |
| 08/10/2000 | WO2000046369A2 Polynucleotides related to pancreatic disease |
| 08/10/2000 | WO2000046368A1 Transporter gene octn3 |
| 08/10/2000 | WO2000046367A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/10/2000 | WO2000046365A1 Advanced antigen presentation platform |
| 08/10/2000 | WO2000046364A1 Fiber receptor-independent system for the propagation of adenoviral vectors |
| 08/10/2000 | WO2000046361A1 Inhibition of the mhc class ii antigen presentation pathway and presentation to cd4+ cells |
| 08/10/2000 | WO2000046359A2 Medicament |
| 08/10/2000 | WO2000046358A2 Arabidopsis thaliana derived frigida gene conferring late flowering |
| 08/10/2000 | WO2000046352A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof |
| 08/10/2000 | WO2000046347A1 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance |
| 08/10/2000 | WO2000046344A2 Non-stochastic generation of genetic vaccines and enzymes |
| 08/10/2000 | WO2000046343A2 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |
| 08/10/2000 | WO2000046250A1 Bacterial signal peptidase inhibitors and uses thereof |
| 08/10/2000 | WO2000046249A1 Method for producing il-1ra, a therapeutically active protein from body fluids |
| 08/10/2000 | WO2000046247A1 Methods of use for dna molecules encoding m68, a tnf receptor-related protein |
| 08/10/2000 | WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 08/10/2000 | WO2000046245A2 Human antibiotic proteins |
| 08/10/2000 | WO2000046244A1 cDNA SEQUENCE OF AN INTERACTOR FANCIP1 OF THE FANCONI ANAEMIA PROTEIN OF COMPLEMENTATION GROUP A |
| 08/10/2000 | WO2000046243A1 Process for preparing coagulants for water treatment |
| 08/10/2000 | WO2000046242A2 19 KILODALTON PROTEIN OF $i(HELICOBACTER PYLORI) |
| 08/10/2000 | WO2000046241A2 Prostate, testis and uterine polypeptide zpep14 |